Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if his Department will make an assessment of the effectiveness of the Pharmacy First initiative in relation to reducing the workload for GP surgeries.

National Health Service pharmaceutical services delivered in community pharmacy are subject to evaluations to assess various outcomes such as clinical appropriateness and impacts on other parts of the NHS. The National Institute of Health and Care Research is conducting an evaluation of Pharmacy First to assess how the service has been implemented across England, including impacts on prescribing in the general practice (GP) setting, use of hospitals and how the service has impacted access and cost for different patient groups.

From July 2024 to February 2025, over 1.7 million Pharmacy First clinical pathway consultations were delivered by community pharmacies. In the same period, over 1.5 million minor illness referrals and 1.4 million consultations for urgent medical supplies were delivered by community pharmacies in England to support patients and help to alleviate the pressure on GP surgeries.

Pharmacy First compliments and enhances the already wide range of services offered by community pharmacy including the provision of health advice and sale of over-the-counter medicines for a wider range of minor illness to support patients to selfcare rather than attend a GP, helping to increase access to care for patients closer to home in their communities.